This chart shows the pharmaceutical companies with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug…
This article was originally published by Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang in Globalization and Health201713:21 under a Creative Commons License. Abstract…
The post Obstacles and opportunities in Chin…
Annual Drug Patent Expirations for METOPROLOL+SUCCINATE Metoprolol Succinate is a drug marketed by Spil, Actavis Elizabeth, Actavis Labs Fl Inc, Dr Reddys Labs Ltd, Mylan Pharms Inc, Nesher Pharms, Novast…
The post New patent for SPIL drug METOPR…
Annual Drug Patent Expirations for LATUDA Latuda is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for Sunovion Pharms drug LATUDA appeared first on DrugPa…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Schering drug REBETOL appeared first…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug REBETOL appeared fi…
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
This chart shows the patent expirations for powder dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Powder dosed drug patent expirations by year appeared first on DrugPatent…
Originally published by J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and Steven V. Molinski in Front. Oncol., 14 November 2017. Abstract The repositioning or…
The post Giving Drugs a Second…
This is a guest post from Susan K Finston, President of Finston Consulting. A little over five years ago I penned the first installment in this irregular series, focused on Israel’s tech transfer prowess and efforts to encourage innovative life-sciences. I tracked the Start-Up Nation’s incremental progress here. In a nutshell, Israel leveraged excellence in basic science and […]